Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Guetta

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
American Heart Journal|December 22, 2019
Impact of preprocedural left ventricle hypertrophy and geometrical patterns on mortality following TAVRZach Rozenbaum, Ariel Finkelstein, Sophia Zhitomirsky, et al.
The American Journal of Cardiology|October 21, 2019
Long-Term Functional and Structural Durability of Bioprosthetic Valves Placed in the Aortic Valve Position via Percutaneous Rout in IsraelKatia Orvin, Sagit Ben Zekry, Olga Morelli, et al.
Journal of the American College of Cardiology|February 21, 2004
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trialHitinder S Gurm, A Michael Lincoff, David Lee, et al.
Circulation|April 20, 2011
Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes TrialMichelle L O'Donoghue, Deepak L Bhatt, Stephen D Wiviott, et al.
The Journal of Invasive Cardiology|April 2, 2022
Generational Differences in Outcomes of Self-Expanding Valves for Transcatheter Aortic Valve ReplacementItamar Loewenstein, Ilan Merdler, Aviram Hochstadt, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 18, 2022
Procedural and long-term outcome among patients undergoing expedited trans-catheter aortic valve replacementAnat Berkovitch, Amit Segev, Victor Guetta, et al.
International Journal of Cardiology|February 26, 2026
The outcome of patients with severe tricuspid regurgitation by body mass indexBoris Fishman, Elad Maor, Saar Ashri, et al.
Journal of the American College of Cardiology|February 26, 2013
Transcatheter aortic valve implantation for pure severe native aortic valve regurgitationDavid A Roy, Ulrich Schaefer, Victor Guetta, et al.
JAMA|November 7, 2002
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trialA Michael Lincoff, Robert M Califf, Frans Van de Werf, et al.
Journal of the American College of Cardiology|August 13, 2016
Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial InfarctionSunil V Rao, Uwe Zeymer, Pamela S Douglas, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
American Heart Journal|December 22, 2019
Impact of preprocedural left ventricle hypertrophy and geometrical patterns on mortality following TAVRZach Rozenbaum, Ariel Finkelstein, Sophia Zhitomirsky, et al.
The American Journal of Cardiology|October 21, 2019
Long-Term Functional and Structural Durability of Bioprosthetic Valves Placed in the Aortic Valve Position via Percutaneous Rout in IsraelKatia Orvin, Sagit Ben Zekry, Olga Morelli, et al.
Journal of the American College of Cardiology|February 21, 2004
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trialHitinder S Gurm, A Michael Lincoff, David Lee, et al.
Circulation|April 20, 2011
Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes TrialMichelle L O'Donoghue, Deepak L Bhatt, Stephen D Wiviott, et al.
The Journal of Invasive Cardiology|April 2, 2022
Generational Differences in Outcomes of Self-Expanding Valves for Transcatheter Aortic Valve ReplacementItamar Loewenstein, Ilan Merdler, Aviram Hochstadt, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 18, 2022
Procedural and long-term outcome among patients undergoing expedited trans-catheter aortic valve replacementAnat Berkovitch, Amit Segev, Victor Guetta, et al.
International Journal of Cardiology|February 26, 2026
The outcome of patients with severe tricuspid regurgitation by body mass indexBoris Fishman, Elad Maor, Saar Ashri, et al.
Journal of the American College of Cardiology|February 26, 2013
Transcatheter aortic valve implantation for pure severe native aortic valve regurgitationDavid A Roy, Ulrich Schaefer, Victor Guetta, et al.
JAMA|November 7, 2002
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trialA Michael Lincoff, Robert M Califf, Frans Van de Werf, et al.
Journal of the American College of Cardiology|August 13, 2016
Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial InfarctionSunil V Rao, Uwe Zeymer, Pamela S Douglas, et al.
Pageof 15